Refine your search
Collections
Co-Authors
Journals
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Shibu Vardhanan, Y.
- Deleterious Missense Single Nucleotide Polymorphism Alters the Structural Conformation of Human Anti-Apoptotic Bcl-2 Protein
Abstract Views :245 |
PDF Views:77
Authors
Affiliations
1 Biochemistry and Toxicology Division, Department of Zoology, University of Calicut, Malappuram 673 635, IN
1 Biochemistry and Toxicology Division, Department of Zoology, University of Calicut, Malappuram 673 635, IN
Source
Current Science, Vol 120, No 4 (2021), Pagination: 666-675Abstract
Identification and understanding the mechanism behind tumorigenesis is crucial for developing new strategies in cancer treatments. In this in silico study, we used the 14 different tools to evaluate the conver-gent deleterious missense Bcl-2 SNPs. Out of 37 mis-sense single nucleotide polymorphism (SNPs), five are deleterious. Molecular modelling and structural and functional evaluation of the mutant proteins were carried out to understand their clinical significance. All deleterious missense SNPs alter the structural stability of the protein. Also H94P deleterious mis-sense SNPs alter the ligand-binding ability of Bcl-2. The results indicate that the mutant antiapoptotic Bcl-2 protein may contribute to tumorigenesis in different ways, depending upon the mutation location.Keywords
Apoptosis, Anti-apoptotic Protein Bcl-2, Deleterious Single Nucleotide Polymorphism, In Silico Evalu-ation, Protein Modelling.Full Text
References
- Green, D. R. and Reed, J. C., Mitochondria and apoptosis. Sci-ence, 1998, 281, 1309–1312.
- Favaloro, B. et al., Role of apoptosis in disease. Aging, 2012, 4(5), 330–349.
- Adams, J. M. and Cory, S., The Bcl-2 protein family: arbiters of cell survival. Science, 1998, 281, 1322–1326.
- Adams, J. M. and Cory, S., The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene, 2007, 26, 1324–1337.
- Andreeff, M. et al., Expression of Bcl-2 related genes in normal and AML progenitors: changes induced by chemotherapy and ret-inoic acid. Leukaemia, 1999, 13, 1881–1892.
- Hanada, M. et al., Structure–function analysis of Bcl-2 protein. Identification of conserved domains important for homodimeriza-tion with Bcl-2 and heterodimerization with Bax. J. Biol. Chem., 1995, 270, 11962–11969.
- Huang, D. C. and Strasser, A., BH3-only proteins essential initia-tor of apoptotic cell death. Cell, 2000, 103, 839–842.
- Maiuri, M. C. et al., BH3-only proteins and BH3 mimetics induce autophagy by competitively disrupting the interaction between Beclin 1 and Bcl-2/Bcl-XL. Autophagy, 2007, 3(4), 374–376.
- Yang, S. E. et al., Down-modulation of Bcl-Xl, release of cyto-chrome c and sequential activation of caspases during honokiol induced apoptosis in human squamous lung cancer CH27 cells. Biochem. Pharamcol., 2002, 63(9), 1641–1651.
- Martinou, J. C. and Youle, R. J., Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev. Cell, 2011, 21(1), 92–101.
- Gross, A., McDonnell, J. M. and Korsmeyer, S. J., Bcl-2 family members and the mitochondria in apoptosis. Genes Dev., 1999, 13(15), 1899–1911.
- Anand, P. P., Computational modelling of human sarcomeric tele-thonin protein and predicting the functional effect of missense single nucleotide polymorphism. Curr. Sci., 2019, 117(4), 638–648; doi:10.18520/cs/v117/i4/638-648.
- Zhang, Y. et al., An antiapoptotic Bcl-2 family protein index pre-dicts the response of leukemia cells to the pan-Bcl-2 inhibitor S1. BJC, 2013, 108, 1870–1878.
- Garcia Saez, A. J., The secrets of the Bcl-2 family. Cell Death Differ., 2012, 19, 1733–1740.
- Zhang, Z. et al., Analyzing effects of naturally occurring missense mutations. Comput. Math. Methods Med., 2012, 805827; doi: 10.1155/2012/805827.
- Rodrigues, C. et al., Performance of in silico tools for the evalua-tion of UGT1A1 missense variants. Hum. Mutat., 2015, 36, 1215–1125.
- Sherry, S. T. et al., dbSNP: the NCBI database of genetic varia-tion. Nucleic Acids Res., 2001, 29, 308–311.
- Pires, A. S. et al., In silico analyses of deleterious missense SNPs of human apolipoprotein E3. Sci. Rep., 2017, 7, 2509.
- Kumar, P., Henikoff, S. and Ng, P. C., Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nature Protoc., 2009, 4, 1073–1081.
- Choi, Y. et al., Predicting the functional effect of amino acid sub-stitutions and indels. PLoS ONE, 2012, 7, e46688; doi:10.1371/ journal.pone.0046688.
- Mi, H. et al., The PANTHER database of protein families, subfa-milies, functions and pathways. Nucleic Acids, 2005, 33,284–288.
- Bendl, J. et al., Predict SNP: robust and accurate consensus classi-fier for prediction of diseases-related mutations. PLoS Comput. Biol., 2014, 10, e1003440.
- Adzhubei, I. et al., A method and server for predicting damaging missense mutations. Nature Methods, 2010, 7, 248–249.
- Niroula, A., Urolagin, S. and Vihinen, M., PON-P2: prediction method for fast and reliable identification of harmful variants. PLoS ONE, 2015, 10, e0117380.
- Cerami et al., The cBIo cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov., 2012, 2, 401–404.
- Gao, J. et al., Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal., 2013, 6.
- Szklarczk, D. et al., The string database in 2017: quality-controlled protein–protein association networks, made broadly accessible. Nucleic Acids Res., 2017, 45, D362–D368.
- Askenazy, H. et al., ConSurf 2010: calculating evolutionary con-servation in sequence and structure of proteins and nucleic acids. Nucleic Acids Res., 2010, 38, W529–W533; doi:10.1093/nar/ gkq399.
- Celniker, G. et al., ConSurf: using evolutionary data to raise testa-ble hypothesis about protein function. Isr. J. Chem., 2013, 53, 199–206.
- Sitao, W. and Zhang, Y., MUSTER: improving protein sequence profile–profile alignments by using multiple sources of structure information. Proteins, 2008, 72(2), 547–556.
- Laskowaski, R. A. et al., PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr., 1993, 26, 283–291.
- Gopalakrishnan, K. et al., Ramachandran plot on the web (2.0). Protein Pept. Lett., 2007, 14, 669–671.
- Arnold, K. et al., The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinfor-matics, 2006, 22, 195–201.
- Laskowaski, R. A., Chistyakov, V. V. and Thornton, J. M., PDB-sum more: new summaries and analyses of the known 3D structure of proteins and nucleic acids. Nucleic Acids Res., 2005, 33, 266–268.
- Venselaar, H., Beek, T. A. H. T., Kuipers, R. K. P., Hekkelman, M. L. and Vriend, G., Protein structure analysis of mutations caus-ing inheritable diseases. An e-Science approach with life scientist friendly interfaces. BMC Bioinformat., 2010, 11(548); doi: 10.1186/1471-2105-1-548.
- Anand, P. P. and Shibu Vardhanan, Y., Computational modelling of wet adhesive mussel foot proteins (Bivalvia): insights into the evolutionary convolution in diverse perspectives. Sci. Rep., 2020, 10, 2612; doi:https://doi.org/10.1038/s41598-020-59169-y.
- Lindahl, E. et al., NOMAD-Ref: visualization, deformation and refinement of macromolecular structures based on all atom normal mode analysis. Nucleic Acids Res., 2006, 34, 52–60.
- Gopalakrishnan, C. et al., Computational modelling of complete HOXb13 protein for predicting the functional effect of SNPs and associated role in hereditary prostate cancer. Sci. Rep., 2017, 7(43830); doi:10.1038/srep43830.
- Pejaver, V., et al., The structural and functional signatures of proteins that undergo multiple events of post-translational modifi-cation. Protein Sci., 2014, 23(8), 1077–1093.
- Kozakov, D. et al., The FTMap family of web servers for deter-mining and characterizing ligand-binding hot spots of proteins. Nature Protoc., 2015, 10(5), 733–755.
- Wang, Z. and Moult, J., Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science, 2001, 292, 727–730.
- Kall, L., Krogh, A. and Sonnhammer, E. LL., Advantages of combined transmembrane topology and signal peptide prediction – Phobius web server. Nucleic Acids Res., 2007, 35; doi:10.1093/nar/ gkm256.
- Day, C. L. et al., Solution structure of pro-survival Mcl-1 and characterization of its binding by proapoptotic BH3-only ligands. J. Biol. Chem., 2005, 280, 4738–4744.
- Proto, W. F., Franco, O. L. and Alencar, S. A., Computational analysis and prediction of guanylin deleterious SNPs. Peptides, 2015, 69, 92–102.
- Frenzel, A. et al., Suppression of B-cell lymphomagenesis by the BH3-only protein Bmf and bad. Blood, 2010, 15, 995–1005.
- Chittenden, T. et al., A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. EMBO J., 1995, 14, 5589–5596.
- Zha, H. et al., Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2. J. Biol. Chem., 1996, 271, 7440–7444.
- Willis, S. et al., The Bcl-2 regulated apoptotic pathway. J. Cell Sci., 2003, 116, 4053–4056; doi:10.1242/jcs.00754.
- Letai A. et al., Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell, 2002, 2, 183–192.
- Martin, L. A. and Dowsett, M., BCL-2: a new therapeutic target in estrogen receptor-positive breast cancer? Cancer Cell, 2013, 24(1), 7–9; doi:10.1016/j.ccr.2013.06.006.
- Diaz, J. L. et al., A common binding site mediates heterodimeriza-tion and homodimerization of Bcl-2 family members. J. Biol. Chem., 1997, 272(17), 11350–11355.
- Van Delft, M. F. and Huang, D. C., How the Bcl-2 family of proteins interact to regulate apoptosis. Cell Res., 2006, 16(2), 203–213.
- Lin, B. et al., Conversion of Bcl-2 from protector to killer by inter-action with nuclear orphan receptor TR3/NGFI-B/Nur77. Cell, 2004, 116, 527–540.
- Chen, Z. X. and Prevaiz, S., Involvement of cytochrome c oxidase subunits Va and Vb in the regulation of cancer cell metabolism by Bcl-2. Cell Death Differ., 2010, 17, 408–420.
- Tanaka, S. et al., Frequent somatic mutations in translocated Bcl-2 gene of non-Hodgkin’s lymphoma patients. Blood, 1992, 79, 229–237.
- Reed, J. C., Bcl-2-family proteins and hematologic malignancies: history and future prospectus. Blood, 2008, 111(7), 3322–3330.